Related references
Note: Only part of the references are listed.Alternatively Activated Macrophages and Airway Disease
Derek E. Byers et al.
CHEST (2011)
Cytokine inhibition in severe asthma: current knowledge and future directions
Jonathan Corren
CURRENT OPINION IN PULMONARY MEDICINE (2011)
ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation
Genevieve Paulissen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production
Dawn C. Newcomb et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Muebeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13Rα2
Marion T. Kasaian et al.
JOURNAL OF IMMUNOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Matrix Metalloproteinase-19 Deficiency Promotes Tenascin-C Accumulation and Allergen-Induced Airway Inflammation
Maud M. Gueders et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
An open-label, single-dose bioavailability study of the pharmacokinetics of CAT-354 after subcutaneous and intravenous administration in healthy males
Chad K. Oh et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Asthma and Allergic Inflammation
Richard M. Locksley
CELL (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
Neutralisation of Interleukin-13 in Mice Prevents Airway Pathology Caused by Chronic Exposure to House Dust Mite
Kate L. Tomlinson et al.
PLOS ONE (2010)
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma
Dave Singh et al.
BMC PULMONARY MEDICINE (2010)
Functions of T cells in asthma: more than just TH2 cells
Clare M. Lloyd et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
C. K. Oh et al.
EUROPEAN RESPIRATORY REVIEW (2010)
Cytokine Antagonists for the Treatment of Asthma Progress to Date
Sabina Antonela Antoniu
BIODRUGS (2009)
Cytokine and anti-cytokine therapy in asthma: ready for the clinic?
D. Desai et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes
L. M. Berry et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
IL-13 as a therapeutic target for respiratory disease
Marion T. Kasaian et al.
BIOCHEMICAL PHARMACOLOGY (2008)
A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma
Maud M. Gueders et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Preclinical Safety and Pharmacology of an Anti-Human Interleukin-13 Monoclonal Antibody in Normal Macaques and in Macaques with Allergic Asthma
Pauline L. Martin et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2008)
The cytokine network in asthma and chronic obstructive pulmonary disease
Peter J. Barnes
JOURNAL OF CLINICAL INVESTIGATION (2008)
Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells
Vivien Chan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice
GY Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling
GY Yang et al.
CYTOKINE (2004)
Effects of anticytokine therapy in a mouse model of chronic asthma
RK Kumar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Receptor internalization is required for eotaxin-induced responses in human eosinophils
N Zimmermann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells
R Venkayya et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin
M Yang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Share Paper
